345 related articles for article (PubMed ID: 28900165)
1. GCN5L1 modulates cross-talk between mitochondria and cell signaling to regulate FoxO1 stability and gluconeogenesis.
Wang L; Scott I; Zhu L; Wu K; Han K; Chen Y; Gucek M; Sack MN
Nat Commun; 2017 Sep; 8(1):523. PubMed ID: 28900165
[TBL] [Abstract][Full Text] [Related]
2. Zbtb7c is a critical gluconeogenic transcription factor that induces glucose-6-phosphatase and phosphoenylpyruvate carboxykinase 1 genes expression during mice fasting.
Choi WI; Yoon JH; Song JY; Jeon BN; Park JM; Koh DI; Ahn YH; Kim KS; Lee IK; Hur MW
Biochim Biophys Acta Gene Regul Mech; 2019 Jun; 1862(6):643-656. PubMed ID: 30959128
[TBL] [Abstract][Full Text] [Related]
3. Type I neuregulin1α is a novel local mediator to suppress hepatic gluconeogenesis in mice.
Arai T; Ono Y; Arimura Y; Sayama K; Suzuki T; Shinjo S; Kanai M; Abe SI; Semba K; Goda N
Sci Rep; 2017 Feb; 7():42959. PubMed ID: 28218289
[TBL] [Abstract][Full Text] [Related]
4. Regulation of hepatic gluconeogenesis by nuclear factor Y transcription factor in mice.
Zhang Y; Guan Q; Liu Y; Zhang Y; Chen Y; Chen J; Liu Y; Su Z
J Biol Chem; 2018 May; 293(20):7894-7904. PubMed ID: 29530977
[TBL] [Abstract][Full Text] [Related]
5. The constitutive androstane receptor activator 4-[(4R,6R)-4,6-diphenyl-1,3-dioxan-2-yl]-N,N-dimethylaniline inhibits the gluconeogenic genes PEPCK and G6Pase through the suppression of HNF4α and FOXO1 transcriptional activity.
Yarushkin AA; Kachaylo EM; Pustylnyak VO
Br J Pharmacol; 2013 Apr; 168(8):1923-32. PubMed ID: 23231652
[TBL] [Abstract][Full Text] [Related]
6. Glucagon regulates hepatic mitochondrial function and biogenesis through FOXO1.
Yang W; Yan H; Pan Q; Shen JZ; Zhou F; Wu C; Sun Y; Guo S
J Endocrinol; 2019 Jun; 241(3):265-278. PubMed ID: 31026811
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-21 regulates hepatic glucose metabolism by targeting FOXO1.
Luo A; Yan H; Liang J; Du C; Zhao X; Sun L; Chen Y
Gene; 2017 Sep; 627():194-201. PubMed ID: 28627440
[TBL] [Abstract][Full Text] [Related]
8. Irisin inhibits hepatic gluconeogenesis and increases glycogen synthesis via the PI3K/Akt pathway in type 2 diabetic mice and hepatocytes.
Liu TY; Shi CX; Gao R; Sun HJ; Xiong XQ; Ding L; Chen Q; Li YH; Wang JJ; Kang YM; Zhu GQ
Clin Sci (Lond); 2015 Nov; 129(10):839-50. PubMed ID: 26201094
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-451 Negatively Regulates Hepatic Glucose Production and Glucose Homeostasis by Targeting Glycerol Kinase-Mediated Gluconeogenesis.
Zhuo S; Yang M; Zhao Y; Chen X; Zhang F; Li N; Yao P; Zhu T; Mei H; Wang S; Li Y; Chen S; Le Y
Diabetes; 2016 Nov; 65(11):3276-3288. PubMed ID: 27495223
[TBL] [Abstract][Full Text] [Related]
10. Evodia alkaloids suppress gluconeogenesis and lipogenesis by activating the constitutive androstane receptor.
Yu L; Wang Z; Huang M; Li Y; Zeng K; Lei J; Hu H; Chen B; Lu J; Xie W; Zeng S
Biochim Biophys Acta; 2016 Sep; 1859(9):1100-1111. PubMed ID: 26455953
[TBL] [Abstract][Full Text] [Related]
11. MiR-19a mediates gluconeogenesis by targeting PTEN in hepatocytes.
Dou L; Wang S; Huang X; Sun X; Zhang Y; Shen T; Guo J; Man Y; Tang W; Li J
Mol Med Rep; 2018 Mar; 17(3):3967-3971. PubMed ID: 29257352
[TBL] [Abstract][Full Text] [Related]
12. Effects of the novel Foxo1 inhibitor AS1708727 on plasma glucose and triglyceride levels in diabetic db/db mice.
Tanaka H; Nagashima T; Shimaya A; Urano Y; Shimokawa T; Shibasaki M
Eur J Pharmacol; 2010 Oct; 645(1-3):185-91. PubMed ID: 20655898
[TBL] [Abstract][Full Text] [Related]
13. Prostaglandin F
Wang Y; Yan S; Xiao B; Zuo S; Zhang Q; Chen G; Yu Y; Chen D; Liu Q; Liu Y; Shen Y; Yu Y
Diabetes; 2018 Sep; 67(9):1748-1760. PubMed ID: 29773555
[TBL] [Abstract][Full Text] [Related]
14. Long non-coding RNA H19 inhibition promotes hyperglycemia in mice by upregulating hepatic FoxO1 levels and promoting gluconeogenesis.
Goyal N; Tiwary S; Kesharwani D; Datta M
J Mol Med (Berl); 2019 Jan; 97(1):115-126. PubMed ID: 30465059
[TBL] [Abstract][Full Text] [Related]
15. TRB1 negatively regulates gluconeogenesis by suppressing the transcriptional activity of FOXO1.
Tsuzuki K; Itoh Y; Inoue Y; Hayashi H
FEBS Lett; 2019 Feb; 593(3):369-380. PubMed ID: 30556236
[TBL] [Abstract][Full Text] [Related]
16. Impaired regulation of hepatic glucose production in mice lacking the forkhead transcription factor Foxo1 in liver.
Matsumoto M; Pocai A; Rossetti L; Depinho RA; Accili D
Cell Metab; 2007 Sep; 6(3):208-16. PubMed ID: 17767907
[TBL] [Abstract][Full Text] [Related]
17. FoxO1 deacetylation regulates thyroid hormone-induced transcription of key hepatic gluconeogenic genes.
Singh BK; Sinha RA; Zhou J; Xie SY; You SH; Gauthier K; Yen PM
J Biol Chem; 2013 Oct; 288(42):30365-30372. PubMed ID: 23995837
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis C virus infection promotes hepatic gluconeogenesis through an NS5A-mediated, FoxO1-dependent pathway.
Deng L; Shoji I; Ogawa W; Kaneda S; Soga T; Jiang DP; Ide YH; Hotta H
J Virol; 2011 Sep; 85(17):8556-68. PubMed ID: 21697492
[TBL] [Abstract][Full Text] [Related]
19. Acute exercise reduces hepatic glucose production through inhibition of the Foxo1/HNF-4alpha pathway in insulin resistant mice.
De Souza CT; Frederico MJ; da Luz G; Cintra DE; Ropelle ER; Pauli JR; Velloso LA
J Physiol; 2010 Jun; 588(Pt 12):2239-53. PubMed ID: 20421289
[TBL] [Abstract][Full Text] [Related]
20. Bradykinin inhibits hepatic gluconeogenesis in obese mice.
Barros CC; Haro A; Russo FJ; Schadock I; Almeida SS; Reis FC; Moraes MR; Haidar A; Hirata AE; Mori M; Bacurau RF; Würtele M; Bader M; Pesquero JB; Araujo RC
Lab Invest; 2012 Oct; 92(10):1419-27. PubMed ID: 22868909
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]